Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.46
-0.01 (-0.18%)
Mar 4, 2026, 4:00 PM EST - Market closed

Artiva Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2022FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-79.19-65.37-28.72-58.79-71.83-17.99
Depreciation & Amortization
2.552.432.271.160.250.07
Stock-Based Compensation
7.426.987.056.584.310.3
Other Adjustments
-2.141.260.254.0818.55-0.28
Change in Receivables
0.621.61-1.23-0.06-0.47-
Changes in Accounts Payable
-0.690.52-0.410.19-1.241.82
Changes in Accrued Expenses
-1.35-0.66-0.91-0.816.442.63
Changes in Unearned Revenue
---26.53-2.4528.97-
Changes in Other Operating Activities
-3.39-1.80.8-0.75-0.28-0.09
Operating Cash Flow
-76.68-55.03-47.43-50.83-15.3-13.54
Capital Expenditures
-2.23-0.64-3.26-6.3-1.72-0.28
Purchases of Investments
-52.19-176.17-49.52---
Proceeds from Sale of Investments
100.8256.3526.8---
Investing Cash Flow
46.41-120.46-25.98-6.3-1.72-0.28
Long-Term Debt Issued
-----3
Net Long-Term Debt Issued (Repaid)
-----3
Issuance of Common Stock
0.53166.560.010.330.180.22
Repurchase of Common Stock
-0.12--0.01-0.01--
Net Common Stock Issued (Repurchased)
0.41166.56-00.330.180.22
Issuance of Preferred Stock
----154.6134.64
Net Preferred Stock Issued (Repurchased)
----154.6134.64
Other Financing Activities
-0.15-4.3324.39-1.59-2.03-0.46
Financing Cash Flow
0.26162.2324.39-1.26152.7537.4
Net Cash Flow
-30.17-13.27-49.01-58.39135.7323.57
Free Cash Flow
-78.91-55.67-50.69-57.13-17.03-13.83
FCF Margin
--22180.88%-151.34%-1158.55%-850.55%-
Free Cash Flow Per Share
-3.23-4.94-63.14-74.51-0.02-0.02
Levered Free Cash Flow
-84.31-65.52-56.76-67.74-2.31-11.4
Unlevered Free Cash Flow
-91.27-67.43-58.63-68.73-20.87-14.12
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q